Spectral AI, Inc. Class A MDAI

DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of the first Site Initiation Visit (“SIV”) associated with the commencement of a clinical study designed to support a label expansion of the Company’s FDA-cleared DeepView System™ for Burn Indication to include burns involvin

DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a scheduled presentation at the upcoming ACS Clinical Congress 2026, being held September 26-29, 2026 in Washington, DC. Entitled “Artificial Intelligence Training & Validation of Multi-Spectral Imaging Device for Evaluation of Burn Wounds